Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1.
about
The striking similarities in the metabolic associations of female androgen excess and male androgen deficiencyFunctional genomics of PCOS: from GWAS to molecular mechanismsObesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cellNuclear factor I revealed as family of promoter binding transcription activators.Nuclear Factor I genomic binding associates with chromatin boundaries.Human cytochrome p450c17: single step purification and phosphorylation of serine 258 by protein kinase a.Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndromeIdentification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome.Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cellsThe Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.Targets to treat androgen excess in polycystic ovary syndrome.Estrogen receptor-alpha mediates an intraovarian negative feedback loop on thecal cell steroidogenesis via modulation of Cyp17a1 (cytochrome P450, steroid 17alpha-hydroxylase/17,20 lyase) expression.SET protein up-regulated testosterone production in the cultured preantral follicles.Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.The BMP4-Smad signaling pathway regulates hyperandrogenism development in a female mouse model.Treatment strategies for women with polycystic ovary syndrome.
P2860
Q26828981-D685AA58-5724-425F-9B4A-9BC431CCF296Q28083015-EB6AA816-39E1-4016-BB7E-F7D80DC075D6Q30406039-92D49D3F-5F8B-45BE-AD13-7238D258E7EDQ30499852-EECD985D-7861-40AC-ABAF-B4E0376580C2Q30538110-897DDB41-C37D-4DB3-BAAC-25BB8CE0CFAEQ33772407-F637C020-5F30-4978-976D-E50D36684571Q34479225-30F600D9-8EF1-4EB9-B132-6C1E6B7F65E7Q34863558-29B4D9A1-DC75-4C3E-A6F0-ED28BE3801A3Q35225482-43CD0FC1-DC9F-41F6-BE7D-2B8CE75BEC29Q35676497-32B895BE-30CE-46BC-B219-F18E0C8CDA53Q35835501-E7679141-32AD-4B7E-BFAF-2573898EF0FAQ35851170-00BB5172-D71E-4AEC-B08B-11B10FAE6118Q36643376-01B23813-23C2-447A-82AD-FFBC3AEA9316Q37071255-1A0DDA00-279F-4780-BFA3-53B97247DDA7Q37711990-4C14B5D6-2709-4DB3-B4F0-B1D80766A5F3Q47744763-8A13E6A9-8C1E-4ACC-AA26-8BE9545E9648Q52859456-6691A229-648D-4A01-B85A-82D695EBAF85
P2860
Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Increased cytochrome P450 17al ...... ome involves nuclear factor-1.
@ast
Increased cytochrome P450 17al ...... ome involves nuclear factor-1.
@en
Increased cytochrome P450 17al ...... ome involves nuclear factor-1.
@nl
type
label
Increased cytochrome P450 17al ...... ome involves nuclear factor-1.
@ast
Increased cytochrome P450 17al ...... ome involves nuclear factor-1.
@en
Increased cytochrome P450 17al ...... ome involves nuclear factor-1.
@nl
prefLabel
Increased cytochrome P450 17al ...... ome involves nuclear factor-1.
@ast
Increased cytochrome P450 17al ...... ome involves nuclear factor-1.
@en
Increased cytochrome P450 17al ...... ome involves nuclear factor-1.
@nl
P2093
P356
P1476
Increased cytochrome P450 17al ...... ome involves nuclear factor-1.
@en
P2093
Jan M McAllister
Jessica K Wickenheisser
Patrick G Quinn
Velen L Nelson-DeGrave
P304
P356
10.1210/ME.2003-0090
P577
2003-12-18T00:00:00Z